Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases
- 1 January 2000
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (2) , 223-224
- https://doi.org/10.1038/sj.bmt.1702124
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescueBone Marrow Transplantation, 1999
- Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell TransplantationBlood, 1998
- Lymphoid Reconstitution After Autologous PBSC Transplantation With FACS-Sorted CD34+ Hematopoietic ProgenitorsBlood, 1998
- The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemiaBone Marrow Transplantation, 1998
- Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrowBone Marrow Transplantation, 1997
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicinBlood, 1994
- Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.Journal of Clinical Oncology, 1994
- T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complicationsBlood, 1990